KSF expands Inspire Medical probe after 2025 guidance cut of more than 80%

The law firm said its review is centered on whether Inspire officers or directors breached fiduciary duties after the company disclosed launch issues tied to Inspire V and faced a securities class action.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.